April 26, 2023
9 min watch
Save
VIDEO: Survey finds positive early impressions with suprachoroidal triamcinolone
Key takeaways:
- Early physician experiences with triamcinolone acetonide suprachoroidal injection were positive.
- Suprachoroidal triamcinolone is effective in patients with scleral buckle and anatomical variations.
NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Peter Y. Chang, MD, discusses early physician experiences with Xipere triamcinolone acetonide suprachoroidal injection.
According to Chang, surgeons should be able to apply their own techniques when using SCS-TA injection after a bit of practice.
“Overall, the 12 physicians that were surveyed for this particular study were all very satisfied,” he said.
Published by:
Sources/Disclosures
Collapse
Source:
Chang PY, et al. Early adoption of triamcinolone acetonide suprachoroidal injection for uveitic macular edema: A physician survey. Presented at: Association for Research in Vision and Ophthalmology meeting; April 23-27, 2023; New Orleans.
Disclosures:
Chang reports consulting for Bausch + Lomb and being a trainer for Xipere.
Read more about